Ackman: It's Very Hard to Find Out the Prices for Drugs

The transcript discusses a communication from Drew Cats about a critical drug pricing issue related to Wilson's disease. The conversation involves Mr. Pearson and Mr. Schiller, who assured that help would be available for those in need. Despite being a major investor, the speaker was unaware of a significant price increase from $6,500 to $26,000. The discussion highlights the challenges of due diligence in the pharmaceutical industry, where drug prices are often negotiated individually with payers.

How much money had the individual invested in the company before the price increase?

What challenges are mentioned regarding due diligence in the pharmaceutical industry?